PATENT CLAIM ANALYSIS

Application Number: 16179174
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["514", "256000"]

Abstract:
The present invention is directed to novel protein kinase inhibitors comprising the chemical compound N-(2-chloro-6-methylphenyl)-2-[[2-methyl-6-(3-hydroxypyrrolidin-1-yl)pyrimidin-4-yl]amino]thiazole-5-carboxamide, its pharmaceutically acceptable salts, enantiomers, and enantiomeric mixtures, and methods of use to treat protein kinase-mediated diseases or conditions.

Claim (Index 13):
The method of  claim 12 , wherein the at least one therapeutic agent is a chemotherapeutic agent, a biologic agent, an immunosuppressive agent, a steroid hormone, and/or non-steroidal anti-inflammatory agent.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 98.0
- Lexical Diversity: 1.22727
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15839469', '15839332', '13403394', '13971793', '14521766']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7549916450862239
- 35 USC 102 Novelty (BERT): 0.5569210460867969
- Combined Prediction Score: 0.7351845851862812
- Mean Citation Score: 357.999914
- Max Citation Score: 434.35107
- Similarity Product: 284.7578739298421

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test